Further studies have shown that miR-214 can inhibit the migration and invasion of gastric cancer cells by directly targeting FGF9 and regulating the EMT process, and its mechanism involves changes in the binding sites of transcription factors with related gene promoter regions, affecting gene expression and thereby influencing the progression of gastric cancer (102). Here, FGF9 is linked to gastric cancer.